Stifel Nicolaus Forecasts Strong Price Appreciation for HLS Therapeutics (TSE:HLS) Stock
HLS Therapeutics (TSE:HLS – Get Free Report) had its price objective upped by equities researchers at Stifel Nicolaus from C$3.50 to C$4.00 in a research report issued on Wednesday,BayStreet.CA reports. The firm currently has a “hold” rating on the stock. Stifel Nicolaus’ price target indicates a potential downside of 11.50% from the company’s previous close. […]
HLS Therapeutics (TSE:HLS – Get Free Report) had its price objective upped by equities researchers at Stifel Nicolaus from C$3.50 to C$4.00 in a research report issued on Wednesday,BayStreet.CA reports. The firm currently has a “hold” rating on the stock. Stifel Nicolaus’ price target indicates a potential downside of 11.50% from the company’s previous close. […]
